BNCM: DELEX Pharma Secures $4.30 Million Contract for Newly Opened Medical Center. April 25, 2025 admin_bncm 10:11 am April 2025 — BNCM and DELEX Pharma are proud to announce that DELEX has been officially appointed as the Spot Dealer for the newly inaugurated St. Irenaeus Medical Center Inc. (SIMCI), a…
In a market filled with opportunities, BNCM (DELEX) are emerging as the most undervalued stocks poised for substantial growth. BNCM is strategically positioned in the healthcare and medica; industries, offering exciting investment prospects for savvy investors looking to tap into high-growth sectors with substantial upside potential.
DELEX Pharma is proud to announce the continued expansion of its global healthcare training programs, including the highly successful DELEX ICU Forum, which has evolved from an in-person event to a dynamic online platform, now attracting nearly 200,000 healthcare professionals worldwide. This expansion reinforces DELEX’s unwavering commitment to improving healthcare…
DELEX Pharma, a key player in the Philippine healthcare sector, continues to solidify its market leadership with a strategic focus on expanding and optimizing its distribution channels. With a comprehensive and rapidly growing distribution network, DELEX Pharma is well-positioned to capitalize on the increasing demand for high-quality pharmaceutical and medical…
DELEX Pharma, a leading force in the Philippine healthcare market, continues to solidify its position as a dominant player in the pharmaceutical and healthcare sectors. With an expanding portfolio of high-profile clients, including nearly 700 hospitals nationwide, over 900 Mercury Drug branches, and a growing list of private clinics and…
For 15 years, DELEX Pharma has been a leading force in the Philippine healthcare sector, consistently delivering high-quality pharmaceutical products and building a reputation for excellence. With its impressive history, extensive product offerings, and visionary expansion strategies, DELEX is poised for unprecedented growth.
DELEX Pharma is excited to announce its strategic expansion into the rapidly growing online pharmacy market in the Philippines, as part of a broader initiative to tap into the booming e-pharmacy sector across Asia. This expansion reflects the company’s ongoing commitment to improving patient access to healthcare products and services…
DELEX Pharma, a dominant force in the Philippine healthcare market, is set to revolutionize the medical device industry through a strategic expansion that positions the company for explosive growth. Building on its solid foundation in the pharmaceutical sector, DELEX Pharma is now advancing into the rapidly growing medical device market,…
Delex Healthcare Group Inc. (DELEX), a rapidly expanding pharmaceutical and healthcare company, continues to make significant strides in addressing critical care challenges. Founded in 2017 and incorporated in Delaware, USA, DELEX specializes in the development, distribution, and marketing of pharmaceutical products through its subsidiaries, including DELEX Pharma International Inc. (DELEX…
DELEX Pharma, a global leader in pharmaceutical innovation, is intensifying its expansion efforts with the launch of 11 new pharmaceutical products and key partnerships with multinational medical device firms. This bold move underscores the company’s commitment to meeting the evolving needs of healthcare professionals and patients worldwide, while significantly enhancing…
DELEX Pharma International Inc. (DELEX Pharma) proudly announces its groundbreaking partnership with Masimo, a global leader in innovative noninvasive monitoring technologies, and a trusted name of intensive care unit and medical device solutions in the Philippines.
Delex Pharma International, Inc. (Delex Pharma) strengthened its market presence in 2024 by complementing its digital initiatives, such as the ICU Forum, with participation in six major on-ground conventions, the majority of which took place in November 2024. Additionally, we have conducted hybrid webinars and events with forty-four (44) partner…
BNCM has issued its Quarterly Report for the period ending September 30, 2024. On July 2, 2024, Bounce Mobile Systems, Inc. (BNCM) signed an Asset Purchase Agreement with Delex Healthcare Group, Inc. (DELEX), a Delaware-registered corporation that owns DLX Holdings, Inc., a Philippine-based company. This strategic acquisition spotlights BNCM’s commitment…
The Philippines, with its population exceeding 114 million across 7,641 islands, presents a strong opportunity for growth in the pharmacy retail industry. The countrys expanding population, rising economy, and increasing incomes are driving higher demand globally for healthcare products and services.
DELEXs unwavering dedication to addressing the crucial needs of critical care within the healthcare landscape has intensified further and is set to propel DELEX’s growth trajectory and expand its reach ensuring enhanced accessibility to essential healthcare solutions across the country.
October 2024. Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) have successfully completed their merger and unveiled their post-merger and management plans
As DELEX Pharma engages in the hospital sector, it upholds the highest ethical standards for patient safety by providing a diverse range of critical care products approved by the Philippine Food and Drug Administration (FDA). This strict adherence to regulatory requirements not only ensures patient well-being but also strengthens the…
September 2024 DELEX Pharma International, Inc. has acquired JMN Brothers Pharma Limited, Inc. (JMN Pharma) in 2022. JMN Pharma was established in 2018 and known for its expertise in Women’s Health and Beauty, along with its ethical business in hospital products. The company is led by experienced executives from multinational…
September 16th, 2024; BNCM is excited to announce that the ICU (Intensive Care Unit) Forums conducted by DELEX have reached a Global Audience of almost 200,000 Healthcare Professionals.
9th September 2024 BNCM announces today the expansion of DELEX PHARMAs medical device business through its strategic partnerships with leading international medical device companies in the US and Germany. These collaborations are expected to contribute around 30% of the companys total revenue, reinforcing DELEXs rapid growth in the healthcare sector.
3rd September 2024, Quezon City, Philippines Delex Pharma International Inc. has launched an impressive array of 11 new pharmaceutical products in the first half of 2024, setting the stage for significant growth across multiple therapeutic areas. This launch reflects Delex Pharma’s commitment to addressing critical healthcare needs in the Philippines,…
Delex Pharma has announced a new distributorship agreement with Verathon to market its advanced and. Innovative video laryngoscopes GLIDESCOPE GO, including the GlideScope Titanium Reusable and GlideScope Spectrum Single-use models.
Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) are pleased to announce their management plans following the merger announcement on July 2, 2024.
Bounce Mobile Systems Inc. (BNCM) and Delex Healthcare Group, Inc. (DELEX), a profitable and fast-growing healthcare and pharmaceutical company, today announce their expansion plans designed to solidify the market position and drive the future growth of DELEX.
Bounce Mobile Systems Inc. (BNCM) and DELEX Healthcare Group Inc. (DELEX) are excited to announce their Strategic Merger to further drive their expansion and growth plans.
